Goldman Sachs Group Analysts Give Gerresheimer (GXI) a €65.00 Price Target
Gerresheimer (ETR:GXI) received a €65.00 ($75.58) price objective from equities research analysts at Goldman Sachs Group in a research note issued on Monday. The brokerage currently has a “neutral” rating on the stock. Goldman Sachs Group’s target price would suggest a potential upside of 13.44% from the stock’s previous close.
A number of other equities research analysts have also recently commented on the stock. Berenberg Bank set a €81.00 ($94.19) price target on shares of Gerresheimer and gave the stock a “buy” rating in a report on Friday, November 23rd. Hauck & Aufhaeuser set a €55.00 ($63.95) price target on shares of Gerresheimer and gave the stock a “neutral” rating in a report on Monday, October 15th. JPMorgan Chase & Co. set a €66.00 ($76.74) price target on shares of Gerresheimer and gave the stock a “neutral” rating in a report on Monday, October 15th. Deutsche Bank set a €86.00 ($100.00) price target on shares of Gerresheimer and gave the stock a “buy” rating in a report on Tuesday, January 15th. Finally, Credit Suisse Group set a €82.00 ($95.35) price target on shares of Gerresheimer and gave the stock a “buy” rating in a report on Tuesday, February 5th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the company’s stock. Gerresheimer currently has a consensus rating of “Hold” and a consensus target price of €68.77 ($79.97).
Shares of ETR GXI opened at €57.30 ($66.63) on Monday. Gerresheimer has a twelve month low of €59.97 ($69.73) and a twelve month high of €78.25 ($90.99).
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
See Also: Channel Trading
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.